Steroid Withdrawal Versus Maintenance in Simultaneous Pancreas–Kidney Transplantation: Long‐Term Outcomes in a Single‐Center Retrospective Cohort
Clinical Transplantation · 2025-11 · 39 (11)
DOI: 10.1111/ctr.70358 ↗At a glance
Vergleichsstudie in Clinical Transplantation, published online on 2025-10-24. Written by Raphael P H Meier and 8 co-authors. Institution: Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, California, USA. Major MEDLINE topics: Pancreas Transplantation, Kidney Transplantation, Graft Rejection, Immunosuppressive Agents. Cited 1 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Simultaneous pancreas and kidney (SPK) transplants using steroid‐free regimens are a frequently used immunosuppressive strategy in low immunologic risk recipients. The long‐term effect on recipient outcomes remains incompletely understood.
Methods
We analyzed post‐transplant outcomes in 307 SPK recipients from a single center, comparing early steroid withdrawal (after completion of Thymoglobulin) with maintenance steroids. Steroid withdrawal was primarily utilized in low immunologic risk patients.
Results
In total, 170 SPK recipients underwent steroid withdrawal, and 137 received maintenance steroids. The withdrawal group had a lower cPRA and included fewer Black recipients. Biopsy‐proven rejection rates (kidney, pancreas, or both) were similar between groups (26% vs. 29%, p = 0.523), with worse kidney/pancreas graft survival among those with rejection. Rejection occurred earliest in recipients rejecting both the kidney and pancreas, followed by those rejecting the kidney alone, and then those rejecting the pancreas. Multivariate analysis showed that kidney and pancreas survival were strongly interdependent. Kidney rejection was the primary predictor of graft survival. The steroid regimen was not independently associated with survival of either organ. Obesity at follow‐up was associated with an increased risk of pancreas graft failure.
Conclusion
In this single‐center cohort, steroid withdrawal was safe in appropriately selected SPK recipients, with rejection—not the steroid regimen—driving long‐term graft outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, California, USA.
- Division of Transplant Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID profiles: Raphael P H Meier, Ali B Abbasi
Cite
APA
Meier, R. P. H., Abbasi, A. B., Gamino, G., Kelly, Y. M., Tavakol, M., Conti, G., Sarwal, M., Stock, P. G., & Freise, C. E. (2025). Steroid Withdrawal Versus Maintenance in Simultaneous Pancreas–Kidney Transplantation: Long‐Term Outcomes in a Single‐Center Retrospective Cohort. Clinical Transplantation, 39(11). https://doi.org/10.1111/ctr.70358
Vancouver
Meier RPH, Abbasi AB, Gamino G, Kelly YM, Tavakol M, Conti G, et al. Steroid Withdrawal Versus Maintenance in Simultaneous Pancreas–Kidney Transplantation: Long‐Term Outcomes in a Single‐Center Retrospective Cohort. Clinical Transplantation. 2025;39(11). doi:10.1111/ctr.70358
BibTeX
@article{Meier2025,
author = {Meier, Raphael P H and Abbasi, Ali B and Gamino, Gerardo and Kelly, Yvonne M and Tavakol, Mehdi and Conti, Giulia and Sarwal, Minnie and Stock, Peter G and Freise, Chris E},
title = {Steroid Withdrawal Versus Maintenance in Simultaneous Pancreas–Kidney Transplantation: Long‐Term Outcomes in a Single‐Center Retrospective Cohort},
journal = {Clinical Transplantation},
year = {2025},
volume = {39},
number = {11},
doi = {10.1111/ctr.70358}
}
EUVIMED